期刊文献+

醒脑静注射液对急性脑梗死患者单核细胞CD_(54)^+分子表达的影响 被引量:11

Influence of Xingnaojing Injection on CD54 molecular expression in patients with acute cerebral infarctions
下载PDF
导出
摘要 目的:探讨醒脑静注射液对急性脑梗死炎症反应的影响。方法:40例急性期脑梗死患者,随机分为2组。对照组20例用常规方法治疗;醒脑静组20例在常规方法治疗的基础上加用醒脑静注射液治疗。观察患者病程第3、10、15日外周血单核细胞(PBMC)CD54分子表达情况,并与20例健康组作比较,同时观察临床疗效。结果:患者第3日PBMCCD+54分子处于高水平表达状态(与健康组比较,P<0.001);第10日时,醒脑静组降至健康组水平(P>0.05),而对照组仍显著高于健康组(P<0.001),至第15日时才达健康组水平(P>0.05);且醒脑静组愈显率65.0%,显著高于对照组30.0%(χ2=4.91,P<0.05)。结论:醒脑静注射液对急性脑梗死炎症反应具有抑制作用,治疗脑梗死患者有效。 Objective :To investigate the influence of Xingnaojing Injection(XNJI) on inflammatory reactions of acute cerebral infarctions. Methods :40 cases of acute phase were selected and randomly divided into two groups.The control group (n=20) was treated with conventional methods otherwise the treatment group treated with the same methods adding XNJI.The conditions of CD54 molecular expression of mononuclear cells in peripheral blood during the ill course on the 3th ,10th and 15th day were observed and compared with healthy subjects (n=20) and meantime the curative effects were abserved too. Results :On the 3th day the CD+54 molecules of mononuclear cells were in a high expression level and in comparison with healthy subjects the difference was significant (P<0001).On the 10th day in XNJI group they were depressed to the same level as that in healthy group (P>005),but in control group they were significantly higher than that in healthy group (P<0001) and till the 15th day they were reached to the level of healthy group (P>005).The markedly effective rate (650%) in XNJI group was significantly higher than that (300%) in control group (2=491,P<005). Conclusions :XNJI possesses inhibiting actions on inflammatory reactions of cerebral infarctions and is able to treat cerebral infarctions effectively.
出处 《中西医结合实用临床急救》 1999年第5期224-225,共2页
关键词 脑梗死 醒脑静注射液 单核细胞 CD^+54分子 acute cerebral infarction \ Xingnaojing Injection \ CD54 molecules of mononuclear expression
  • 相关文献

参考文献5

二级参考文献5

共引文献106

同被引文献130

引证文献11

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部